Both in Pharmaceuticals
Telomir Pharmaceuticals vs Spero Therapeutics
Over the past year TELO returned −26.8% and SPRO returned −49.8%; their daily moves had a correlation of 0.22.
TELO −26.8% SPRO −49.8%Growth of $1, one year, split-adjusted
| Metric | TELO | SPRO |
|---|---|---|
| Price | $1.01 | $1.13 |
| Market cap | $74.4M | $65.8M |
| Today | −0.98% | −3.42% |
| 1 month | −17.2% | −10.3% |
| 6 months | −26.8% | −59.6% |
| Year to date | −24.1% | −51.5% |
| 1 year | −32.7% | −52.3% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 8.9× |
| Price / sales | — | 1.4× |
| Net cash | $5.0M | $50.7M |
| Dividend yield | — | — |
| Volatility (60d) | 48.1% | 57.1% |
| Short % of float | 2.2% | 1.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).